Respiratory Implications of Pediatric Neuromuscular Disease

References

1. 1.↵
   1. Perrin C,
   2. Unterborn JN,
   3. Ambrosio CD,
   4. Hill NS

   . Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29(1):5–27.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Brain JD,
   2. Proctor D,
   3. Reid L

   1. Leith DE

   . Cough. In: Brain JD, Proctor D, Reid L, editors. Respiratory defense mechanisms, Part II. New York: Marcel Dekker; 1977:545–592.
3. 3.↵
   1. Roussos C,
   2. Macklem PT

   . The respiratory muscles. N Engl J Med 1982;307(13):786–797.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Fink JB

   . Forced expiratory technique, directed cough, and autogenic drainage. Respir Care 2007;52(9):1210–1221; discussion 1221-1213.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Warwick WJ

   . Mechanisms of mucous transport. Eur J Respir Dis Suppl 1983;127:162–167.

   OpenUrlPubMed
6. 6.↵
   1. Leith DE

   . The development of cough. Am Rev Respir Dis 1985;131(5):S39–S42.

   OpenUrlPubMed
7. 7.↵
   1. Bach JR,
   2. Saporito LR

   . Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure: a different approach to weaning. Chest 1996;110(6):1566–1571.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Szeinberg A,
   2. Tabachnik E,
   3. Rashed N,
   4. McLaughlin FJ,
   5. England S,
   6. Bryan CA,
   7. Levison H

   . Cough capacity in patients with muscular dystrophy. Chest 1988;94(6):1232–1235.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Mier-Jedrzejowicz A,
   2. Brophy C,
   3. Green M

   . Respiratory muscle weakness during upper respiratory tract infections. Am Rev Respir Dis 1988;138(1):5–7.

   OpenUrlPubMedWeb of Science
10. 10.↵
    1. Poponick JM,
    2. Jacobs I,
    3. Supinski G,
    4. DiMarco AF

    . Effect of upper respiratory tract infection in patients with neuromuscular disease. Am J Respir Crit Care Med 1997;156(2 Pt 1):659–664.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Tzeng AC,
    2. Bach JR

    . Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 2000;118(5):1390–1396.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Bach JR,
    2. Ishikawa Y,
    3. Kim H

    . Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997;112(4):1024–1028.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Finder JD,
    2. Birnkrant D,
    3. Carl J,
    4. Farber HJ,
    5. Gozal D,
    6. Iannaccone ST,
    7. et al

    . Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004;170(4):456–465.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Hull J,
    2. Aniapravan R,
    3. Chan E,
    4. Chatwin M,
    5. Forton J,
    6. Gallagher J,
    7. et al

    . British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax 2012;67(Suppl 1):i1–i40.

    OpenUrlFREE Full Text
15. 15.↵
    1. Toussaint M,
    2. Boitano LJ,
    3. Gathot V,
    4. Steens M,
    5. Soudon P

    . Limits of effective cough-augmentation techniques in patients with neuromuscular disease. Respir Care 2009;54(3):359–366.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Croteau JR,
    2. Cook CD

    . Volume-pressure and length-tension measurements in human tracheal and bronchial segments. J Appl Physiol 1961;16:170–172.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Bianchi C,
    2. Baiardi P

    . Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil 2008;87(6):461–467.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Wang CH,
    2. Finkel RS,
    3. Bertini ES,
    4. Schroth M,
    5. Simonds A,
    6. Wong B,
    7. et al

    . Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007;22(8):1027–1049.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Dail CW

    . “Glossopharyngeal breathing” by paralyzed patients; a preliminary report. Calif Med 1951;75(3):217–218.

    OpenUrlPubMed
20. 20.↵
    1. Braun SR,
    2. Giovannoni R,
    3. O'Connor M

    . Improving the cough in patients with spinal cord injury. Am J Phys Med 1984;63(1):1–10.

    OpenUrlPubMedWeb of Science
21. 21.↵
    1. Kirby NA,
    2. Barnerias MJ,
    3. Siebens AA

    . An evaluation of assisted cough in quadriparetic patients. Arch Phys Med Rehabil 1966;47(11):705–710.

    OpenUrlPubMed
22. 22.↵
    1. Bach JR

    . Mechanical insufflation-exsufflation: comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest 1993;104(5):1553–1562.

    OpenUrlPubMedWeb of Science
23. 23.↵
    1. Birnkrant DJ,
    2. Pope JF,
    3. Lewarski J,
    4. Stegmaier J,
    5. Besunder JB

    . Persistent pulmonary consolidation treated with intrapulmonary percussive ventilation: a preliminary report. Pediatr Pulmonol 1996;21(4):246–249.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Reardon CC,
    2. Christiansen D,
    3. Barnett ED,
    4. Cabral HJ

    . Intrapulmonary percussive ventilation vs incentive spirometry for children with neuromuscular disease. Arch Pediatr Adolesc Med 2005;159(6):526–531.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Toussaint M,
    2. De Win H,
    3. Steens M,
    4. Soudon P

    . Effect of intrapulmonary percussive ventilation on mucus clearance in Duchenne muscular dystrophy patients: a preliminary report. Respir Care 2003;48(10):940–947.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Fitzgerald K,
    2. Dugre J,
    3. Pagala S,
    4. Homel P,
    5. Marcus M,
    6. Kazachkov M

    . High-frequency chest wall compression therapy in neurologically impaired children. Respir Care 2014;59(1):107–112.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Giarraffa P,
    2. Berger KI,
    3. Chaikin AA,
    4. Axelrod FB,
    5. Davey C,
    6. Becker B

    . Assessing efficacy of high-frequency chest wall oscillation in patients with familial dysautonomia. Chest 2005;128(5):3377–3381.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Plioplys AV,
    2. Lewis S,
    3. Kasnicka I

    . Pulmonary vest therapy in pediatric long-term care. J Am Med Dir Assoc 2002;3(5):318–321.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Hendriks T,
    2. de Hoog M,
    3. Lequin MH,
    4. Devos AS,
    5. Merkus PJ

    . DNase and atelectasis in non-cystic fibrosis pediatric patients. Crit Care 2005;9(4):R351–R356.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.
    1. McLaughlin AM,
    2. McGrath E,
    3. Barry R,
    4. Egan JJ,
    5. Gallagher CG

    . Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis? Clin Respir J 2008;2(2):123–126.

    OpenUrlPubMedWeb of Science
31. 31.↵
    1. Rogers DF

    . Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007;52(9):1176–1193; discussion 1193-1177.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Thornby KA,
    2. Johnson A,
    3. Axtell S

    . Dornase alfa for non-cystic fibrosis pediatric pulmonary atelectasis. Ann Pharmacother 2014;48(8):1040–1049.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Hess DR

    . The evidence for secretion clearance techniques. Respir Care 2001;46(11):1276–1293.

    OpenUrlPubMed
34. 34.↵
    1. Bach JR,
    2. Smith WH,
    3. Michaels J,
    4. Saporito L,
    5. Alba AS,
    6. Dayal R,
    7. Pan J

    . Airway secretion clearance by mechanical exsufflation for post-poliomyelitis ventilator-assisted individuals. Arch Phys Med Rehabil 1993;74(2):170–177.

    OpenUrlPubMedWeb of Science
35. 35.↵
    1. Chatwin M,
    2. Ross E,
    3. Hart N,
    4. Nickol AH,
    5. Polkey MI,
    6. Simonds AK

    . Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J 2003;21(3):502–508.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Kang SW,
    2. Bach JR

    . Maximum insufflation capacity: vital capacity and cough flows in neuromuscular disease. Am J Phys Med Rehabil 2000;79(3):222–227.

    OpenUrlCrossRefPubMedWeb of Science
37. 37.↵
    1. Senent C,
    2. Golmard JL,
    3. Salachas F,
    4. Chiner E,
    5. Morelot-Panzini C,
    6. Meninger V,
    7. et al

    . A comparison of assisted cough techniques in stable patients with severe respiratory insufficiency due to amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12(1):26–32.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Boitano LJ

    . Management of airway clearance in neuromuscular disease. Respir Care 2006;51(8):913–922; discussion 922-914.

    OpenUrlAbstract/FREE Full Text
39. 39.↵
    1. Ishikawa Y,
    2. Bach JR,
    3. Komaroff E,
    4. Miura T,
    5. Jackson-Parekh R

    . Cough augmentation in Duchenne muscular dystrophy. Am J Phys Med Rehabil 2008;87(9):726–730.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Trebbia G,
    2. Lacombe M,
    3. Fermanian C,
    4. Falaize L,
    5. Lejaille M,
    6. Louis A,
    7. et al

    . Cough determinants in patients with neuromuscular disease. Respir Physiol Neurobiol 2005;146(2):291–300.

    OpenUrlCrossRefPubMedWeb of Science
41. 41.↵
    1. Toussaint M,
    2. Pernet K,
    3. Steens M,
    4. Haan J,
    5. Sheers N

    . Cough augmentation in subjects with duchenne muscular dystrophy: comparison of air stacking via a resuscitator bag versus mechanical ventilation. Respir Care 2016;61(1):61–67.

    OpenUrlAbstract/FREE Full Text
42. 42.↵
    1. Homnick DN

    . Mechanical insufflation-exsufflation for airway mucus clearance. Respir Care 2007;52(10):1296–1305; discussion 1306-1297.

    OpenUrlAbstract/FREE Full Text
43. 43.↵
    1. Miske LJ,
    2. Hickey EM,
    3. Kolb SM,
    4. Weiner DJ,
    5. Panitch HB

    . Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 2004;125(4):1406–1412.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    1. Gómez-Merino E,
    2. Sancho J,
    3. Marín J,
    4. Servera E,
    5. Blasco ML,
    6. Belda FJ,
    7. et al

    . Mechanical insufflation-exsufflation: pressure, volume, and flow relationships and the adequacy of the manufacturer's guidelines. Am J Phys Med Rehabil 2002;81(8):579–583.

    OpenUrlCrossRefPubMedWeb of Science
45. 45.↵
    1. Sancho J,
    2. Servera E,
    3. Marín J,
    4. Vergara P,
    5. Belda FJ,
    6. Bach JR

    . Effect of lung mechanics on mechanically assisted flows and volumes. Am J Phys Med Rehabil 2004;83(9):698–703.

    OpenUrlPubMed
46. 46.↵
    1. Frigerio P,
    2. Longhini F,
    3. Sommariva M,
    4. Stagni EG,
    5. Curto F,
    6. Redaelli T,
    7. et al

    . Bench comparative assessment of mechanically assisted cough devices. Respir Care 2015;60(7):975–982.

    OpenUrlAbstract/FREE Full Text
47. 47.↵
    1. Striegl AM,
    2. Redding GJ,
    3. Diblasi R,
    4. Crotwell D,
    5. Salyer J,
    6. Carter ER

    . Use of a lung model to assess mechanical in-exsufflator therapy in infants with tracheostomy. Pediatr Pulmonol 2011;46(3):211–217.

    OpenUrl
48. 48.↵
    1. Suri P,
    2. Burns SP,
    3. Bach JR

    . Pneumothorax associated with mechanical insufflation-exsufflation and related factors. Am J Phys Med Rehabil 2008;87(11):951–955.

    OpenUrlCrossRefPubMedWeb of Science
49. 49.↵
    1. Gee SL,
    2. Lowe GR,
    3. Warren RH

    . Complications with utilization of positive-pressure devices in a young man with Duchenne muscular dystrophy. Respir Care 2015;60(2):e30–e33.

    OpenUrlAbstract/FREE Full Text
50. 50.↵
    1. Sancho J,
    2. Servera E,
    3. Díaz J,
    4. Marín J

    . Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest 2004;125(4):1400–1405.

    OpenUrlCrossRefPubMedWeb of Science
51. 51.↵
    1. Andersen T,
    2. Sandnes A,
    3. Hilland M,
    4. Halvorsen T,
    5. Fondenes O,
    6. Heimdal JH,
    7. et al

    . Laryngeal response patterns to mechanical insufflation-exsufflation in healthy subjects. Am J Phys Med Rehabil 2013;92(10):920–929.

    OpenUrlCrossRefPubMed
52. 52.↵
    1. Miske LJ,
    2. McDonough JM,
    3. Weiner DJ,
    4. Panitch HB

    . Changes in gastric pressure and volume during mechanical in-exsufflation. Pediatr Pulmonol 2013;48(8):824–829.

    OpenUrl
53. 53.↵
    1. Morrow B,
    2. Zampoli M,
    3. van Aswegen H,
    4. Argent A

    . Mechanical insufflation-exsufflation for people with neuromuscular disorders. Cochrane Database Syst Rev 2013;(12):CD010044.
54. 54.↵
    1. Vianello A,
    2. Corrado A,
    3. Arcaro G,
    4. Gallan F,
    5. Ori C,
    6. Minuzzo M,
    7. Bevilacqua M

    . Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil 2005;84(2):83–88; discussion 89-91.

    OpenUrlCrossRefPubMedWeb of Science
55. 55.↵
    1. Chatwin M,
    2. Simonds AK

    . The addition of mechanical insufflation/exsufflation shortens airway-clearance sessions in neuromuscular patients with chest infection. Respir Care 2009;54(11):1473–1479.

    OpenUrlAbstract/FREE Full Text
56. 56.↵
    1. Moran FC,
    2. Spittle A,
    3. Delany C,
    4. Robertson CF,
    5. Massie J

    . Effect of home mechanical in-exsufflation on hospitalisation and life-style in neuromuscular disease: a pilot study. J Paediatr Child Health 2013;49(3):233–237.

    OpenUrlPubMed
57. 57.↵
    1. Mahede T,
    2. Davis G,
    3. Rutkay A,
    4. Baxendale S,
    5. Sun W,
    6. Dawkins HJ,
    7. et al

    . Use of mechanical airway clearance devices in the home by people with neuromuscular disorders: effects on health service use and lifestyle benefits. Orphanet J Rare Dis 2015;10:54.

    OpenUrl
58. 58.↵
    1. Moran FC,
    2. Spittle AJ,
    3. Delany C

    . Lifestyle implications of home mechanical insufflation-exsufflation for children with neuromuscular disease and their families. Respir Care 2015;60(7):967–974.

    OpenUrlAbstract/FREE Full Text
59. 59.↵
    1. Bird FM

    . Intrapulmonary percussive ventilation (IPV). Flying Physician 1987;30:4–8.

    OpenUrl
60. 60.↵
    1. Langenderfer B

    . Alternatives to percussion and postural drainage: a review of mucus clearance therapies: percussion and postural drainage, autogenic drainage, positive expiratory pressure, flutter valve, intrapulmonary percussive ventilation, and high-frequency chest compression with the ThAIRapy Vest. J Cardiopulm Rehabil 1998;18(4):283–289.

    OpenUrlCrossRefPubMed
61. 61.↵
    1. Homnick DN,
    2. White F,
    3. de Castro C

    . Comparison of effects of an intrapulmonary percussive ventilator to standard aerosol and chest physiotherapy in treatment of cystic fibrosis. Pediatr Pulmonol 1995;20(1):50–55.

    OpenUrlPubMedWeb of Science
62. 62.↵
    1. Natale JE,
    2. Pfeifle J,
    3. Homnick DN

    . Comparison of intrapulmonary percussive ventilation and chest physiotherapy: a pilot study in patients with cystic fibrosis. Chest 1994;105(6):1789–1793.

    OpenUrlCrossRefPubMedWeb of Science
63. 63.↵
    1. Reychler G,
    2. Keyeux A,
    3. Cremers C,
    4. Veriter C,
    5. Rodenstein DO,
    6. Liistro G

    . Comparison of lung deposition in two types of nebulization: intrapulmonary percussive ventilation vs jet nebulization. Chest 2004;125(2):502–508.

    OpenUrlCrossRefPubMed
64. 64.↵
    1. Reychler G,
    2. Wallemacq P,
    3. Rodenstein DO,
    4. Cumps J,
    5. Leal T,
    6. Liistro G

    . Comparison of lung deposition of amikacin by intrapulmonary percussive ventilation and jet nebulization by urinary monitoring. J Aerosol Med 2006;19(2):199–207.

    OpenUrlPubMed
65. 65.↵
    1. Toussaint M,
    2. Guillet MC,
    3. Paternotte S,
    4. Soudon P,
    5. Haan J

    . Intrapulmonary effects of setting parameters in portable intrapulmonary percussive ventilation devices. Respir Care 2012;57(5):735–742.

    OpenUrlAbstract/FREE Full Text
66. 66.↵
    1. Freitag L,
    2. Long WM,
    3. Kim CS,
    4. Wanner A

    . Removal of excessive bronchial secretions by asymmetric high-frequency oscillations. J Appl Physiol 1989;67(2):614–619.

    OpenUrlAbstract/FREE Full Text
67. 67.↵
    1. Deakins K,
    2. Chatburn RL

    . A comparison of intrapulmonary percussive ventilation and conventional chest physiotherapy for the treatment of atelectasis in the pediatric patient. Respir Care 2002;47(10):1162–1167.

    OpenUrlPubMed
68. 68.↵
    1. Chang HK,
    2. Weber ME,
    3. King M

    . Mucus transport by high-frequency nonsymmetrical oscillatory airflow. J Appl Physiol 1988;65(3):1203–1209.

    OpenUrlAbstract/FREE Full Text
69. 69.↵
    1. King M,
    2. Zidulka A,
    3. Phillips DM,
    4. Wight D,
    5. Gross D,
    6. Chang HK

    . Tracheal mucus clearance in high-frequency oscillation: effect of peak flow rate bias. Eur Respir J 1990;3(1):6–13.

    OpenUrlAbstract/FREE Full Text
70. 70.↵
    1. Sturgess JM,
    2. Palfrey AJ,
    3. Reid L

    . The viscosity of bronchial secretion. Clin Sci 1970;38(1):145–156.

    OpenUrl
71. 71.↵
    1. Bateman JR,
    2. Newman SP,
    3. Daunt KM,
    4. Sheahan NF,
    5. Pavia D,
    6. Clarke SW

    . Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax 1981;36(9):683–687.

    OpenUrlAbstract/FREE Full Text
72. 72.↵
    1. Gross D,
    2. Zidulka A,
    3. O'Brien C,
    4. Wight D,
    5. Fraser R,
    6. Rosenthal L,
    7. King M

    . Peripheral mucociliary clearance with high-frequency chest wall compression. J Appl Physiol 1985;58(4):1157–1163.

    OpenUrlAbstract/FREE Full Text
73. 73.↵
    1. Arens R,
    2. Gozal D,
    3. Omlin KJ,
    4. Vega J,
    5. Boyd KP,
    6. Keens TG,
    7. Woo MS

    . Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med 1994;150(4):1154–1157.

    OpenUrlCrossRefPubMedWeb of Science
74. 74.↵
    1. Warwick WJ,
    2. Hansen LG

    . The long-term effect of high-frequency chest compression therapy on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1991;11(3):265–271.

    OpenUrlCrossRefPubMedWeb of Science
75. 75.↵
    1. Crescimanno G,
    2. Marrone O

    . High frequency chest wall oscillation plus mechanical in-exsufflation in Duchenne muscular dystrophy with respiratory complications related to pandemic influenza A/H1N1. Rev Port Pneumol 2010;16(6):912–916.

    OpenUrlPubMed
76. 76.
    1. Keating JM,
    2. Collins N,
    3. Bush A,
    4. Chatwin M

    . High-frequency chest-wall oscillation in a noninvasive-ventilation-dependent patient with type 1 spinal muscular atrophy. Respir Care 2011;56(11):1840–1843.

    OpenUrlAbstract/FREE Full Text
77. 77.↵
    1. Wampole A,
    2. Schroth M,
    3. Boriosi J

    . Survival of a child with spinal muscular atrophy and acute respiratory distress syndrome. Pediatr Pulmonol 2015;50(8):E29–E31.

    OpenUrl
78. 78.↵
    1. Willis LD,
    2. Warren RH

    . Acute hypoxemia in a child with neurologic impairment associated with high-frequency chest-wall compression. Respir Care 2007;52(8):1027–1029.

    OpenUrlAbstract/FREE Full Text
79. 79.↵
    1. Yuan N,
    2. Kane P,
    3. Shelton K,
    4. Matel J,
    5. Becker BC,
    6. Moss RB

    . Safety, tolerability, and efficacy of high-frequency chest wall oscillation in pediatric patients with cerebral palsy and neuromuscular diseases: an exploratory randomized controlled trial. J Child Neurol 2010;25(7):815–821.

    OpenUrlCrossRefPubMed
80. 80.↵
    1. Lechtzin N,
    2. Wolfe LF,
    3. Frick KD

    . The impact of high frequency chest wall oscillation on healthcare utilization in patients with neuromuscular diseases. Ann Am Thorac Soc 2016;13(6):904–909.

    OpenUrl
81. 81.↵
    1. Smyth AR,
    2. Barbato A,
    3. Beydon N,
    4. Bisgaard H,
    5. de Boeck K,
    6. Brand P,
    7. et al

    . Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J 2010;35(2):247–265.

    OpenUrlAbstract/FREE Full Text
82. 82.↵
    1. Strickland SL,
    2. Rubin BK,
    3. Haas CF,
    4. Volsko TA,
    5. Drescher GS,
    6. O'Malley CA

    . AARC clinical practice guideline: effectiveness of pharmacologic airway clearance therapies in hospitalized patients. Respir Care 2015;60(7):1071–1077.

    OpenUrlAbstract/FREE Full Text
83. 83.↵
    1. Birnkrant DJ,
    2. Panitch HB,
    3. Benditt JO,
    4. Boitano LJ,
    5. Carter ER,
    6. Cwik VA,
    7. et al

    . American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest 2007;132(6):1977–1986.

    OpenUrlCrossRefPubMedWeb of Science
84. 84.↵
    1. Voelker KG,
    2. Chetty KG,
    3. Mahutte CK

    . Resolution of recurrent atelectasis in spinal cord injury patients with administration of recombinant human DNase. Intensive Care Med 1996;22(6):582–584.

    OpenUrlPubMedWeb of Science
85. 85.↵
    1. Fuchs HJ,
    2. Borowitz DS,
    3. Christiansen DH,
    4. Morris EM,
    5. Nash ML,
    6. Ramsey BW,
    7. et al

    . Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis: The Pulmozyme Study Group. N Engl J Med 1994;331(10):637–642.

    OpenUrlCrossRefPubMedWeb of Science
86. 86.↵
    1. Jones AP,
    2. Wallis C

    . Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev 2010;(3):CD001127.
87. 87.↵
    1. Crescimanno G,
    2. Marrone O

    . Successful treatment of atelectasis with dornase alpha in a patient with congenital muscular dystrophy. Rev Port Pneumol 2014;20(1):42–45.

    OpenUrl
88. 88.↵
    1. O'Donnell AE,
    2. Barker AF,
    3. Ilowite JS,
    4. Fick RB

    . Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I: rhDNase Study Group. Chest 1998;113(5):1329–1334.

    OpenUrlCrossRefPubMedWeb of Science
89. 89.↵
    1. Elkins MR,
    2. Robinson M,
    3. Rose BR,
    4. Harbour C,
    5. Moriarty CP,
    6. Marks GB,
    7. et al

    . A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006;354(3):229–240.

    OpenUrlCrossRefPubMedWeb of Science
90. 90.↵
    1. Zhang L,
    2. Mendoza-Sassi RA,
    3. Klassen TP,
    4. Wainwright C

    . Nebulized hypertonic saline for acute bronchiolitis: a systematic review. Pediatrics 2015;136(4):687–701.

    OpenUrlAbstract/FREE Full Text
91. 91.↵
    1. Elkins MR,
    2. Bye PT

    . Mechanisms and applications of hypertonic saline. J R Soc Med 2011;104(Suppl 1):S2–S5.

    OpenUrlCrossRefPubMed
92. 92.↵
    1. Brightling CE

    . Clinical applications of induced sputum. Chest 2006;129(5):1344–1348.

    OpenUrlCrossRefPubMedWeb of Science
93. 93.↵
    1. Hirsh AJ

    . Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents. Adv Drug Deliv Rev 2002;54(11):1445–1462.

    OpenUrlCrossRefPubMedWeb of Science
94. 94.↵
    1. King M,
    2. Dasgupta B,
    3. Tomkiewicz RP,
    4. Brown NE

    . Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. Am J Respir Crit Care Med 1997;156(1):173–177.

    OpenUrlCrossRefPubMedWeb of Science
95. 95.↵
    1. Gould NS,
    2. Gauthier S,
    3. Kariya CT,
    4. Min E,
    5. Huang J,
    6. Brian DJ

    . Hypertonic saline increases lung epithelial lining fluid glutathione and thiocyanate: two protective CFTR-dependent thiols against oxidative injury. Respir Res 2010;11:119.

    OpenUrlCrossRefPubMed
96. 96.↵
    1. Reeves EP,
    2. Williamson M,
    3. O'Neill SJ,
    4. Greally P,
    5. McElvaney NG

    . Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 2011;183(11):1517–1523.

    OpenUrlCrossRefPubMedWeb of Science
97. 97.↵
    1. Kishioka C,
    2. Okamoto K,
    3. Kim JS,
    4. Rubin BK

    . Hyperosmolar solutions stimulate mucus secretion in the ferret trachea. Chest 2003;124(1):306–313.

    OpenUrlCrossRefPubMed
98. 98.↵
    1. Valderramas SR,
    2. Atallah AN

    . Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial. Respir Care 2009;54(3):327–333.

    OpenUrlAbstract/FREE Full Text
99. 99.↵
    1. Shein SL,
    2. Gallagher JT,
    3. Deakins KM,
    4. Weinert DM

    . Prophylactic use of nebulized hypertonic saline in mechanically ventilated children: a randomized blinded pilot study. Respir Care 2016;61(5):586–592.

    OpenUrlAbstract/FREE Full Text
100. 100.↵
     1. Bennett WD,
     2. Wu J,
     3. Fuller F,
     4. Balcazar JR,
     5. Zeman KL,
     6. Duckworth H,
     7. et al

     . Duration of action of hypertonic saline on mucociliary clearance in the normal lung. J Appl Physiol 2015;118(12):1483–1490.

     OpenUrlAbstract/FREE Full Text
101. 101.↵
     1. Bateman ED,
     2. Rennard S,
     3. Barnes PJ,
     4. Dicpinigaitis PV,
     5. Gosens R,
     6. Gross NJ,
     7. et al

     . Alternative mechanisms for tiotropium. Pulm Pharmacol Ther 2009;22(6):533–542.

     OpenUrlCrossRefPubMed
102. 102.↵
     1. Kishioka C,
     2. Okamoto K,
     3. Kim J,
     4. Rubin BK

     . Regulation of secretion from mucous and serous cells in the excised ferret trachea. Respir Physiol 2001;126(2):163–171.

     OpenUrlCrossRefPubMedWeb of Science
103. 103.↵
     1. Tagaya E,
     2. Yagi O,
     3. Sato A,
     4. Arimura K,
     5. Takeyama K,
     6. Kondo M,
     7. Tamaoki J

     . Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD. Pulm Pharmacol Ther 2016;39:81–84.

     OpenUrl
104. 104.↵
     1. Blasco PA,
     2. Stansbury JC

     . Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 1996;150(9):932–935.

     OpenUrlCrossRefPubMedWeb of Science
105. 105.↵
     1. Garnock-Jones KP

     . Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions. Paediatr Drugs 2012;14(4):263–269.

     OpenUrlCrossRefPubMed
106. 106.↵
     1. Thomsen TR,
     2. Galpern WR,
     3. Asante A,
     4. Arenovich T,
     5. Fox SH

     . Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease. Mov Disord 2007;22(15):2268–2273.

     OpenUrlPubMed
107. 107.↵
     1. Mier RJ,
     2. Bachrach SJ,
     3. Lakin RC,
     4. Barker T,
     5. Childs J,
     6. Moran M

     . Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000;154(12):1214–1218.

     OpenUrlCrossRefPubMedWeb of Science
108. 108.↵
     1. Alves RS,
     2. Resende MB,
     3. Skomro RP,
     4. Souza FJ,
     5. Reed UC

     . Sleep and neuromuscular disorders in children. Sleep Med Rev 2009;13(2):133–148.

     OpenUrlPubMed
109. 109.↵
     1. Arens R,
     2. Muzumdar H

     . Sleep, sleep disordered breathing, and nocturnal hypoventilation in children with neuromuscular diseases. Paediatr Respir Rev 2010;11(1):24–30.

     OpenUrlCrossRefPubMed
110. 110.↵
     1. Piper A

     . Sleep abnormalities associated with neuromuscular disease: pathophysiology and evaluation. Semin Respir Crit Care Med 2002;23(3):211–219.

     OpenUrlPubMed
111. 111.↵
     1. Phillipson EA

     . Control of breathing during sleep. Am Rev Respir Dis 1978;118(5):909–939.

     OpenUrlPubMedWeb of Science
112. 112.↵
     1. Lopes JM,
     2. Tabachnik E,
     3. Muller NL,
     4. Levison H,
     5. Bryan AC

     . Total airway resistance and respiratory muscle activity during sleep. J Appl Physiol Respir Environ Exerc Physiol 1983;54(3):773–777.

     OpenUrlFREE Full Text
113. 113.↵
     1. Tabachnik E,
     2. Muller NL,
     3. Bryan AC,
     4. Levison H

     . Changes in ventilation and chest wall mechanics during sleep in normal adolescents. J Appl Physiol Respir Environ Exerc Physiol 1981;51(3):557–564.

     OpenUrlAbstract/FREE Full Text
114. 114.↵
     1. Dhand UK,
     2. Dhand R

     . Sleep disorders in neuromuscular diseases. Curr Opin Pulm Med 2006;12(6):402–408.

     OpenUrlCrossRefPubMed
115. 115.↵
     1. Dolmage TE,
     2. Avendano MA,
     3. Goldstein RS

     . Respiratory function during wakefulness and sleep among survivors of respiratory and non-respiratory poliomyelitis. Eur Respir J 1992;5(7):864–870.

     OpenUrlAbstract/FREE Full Text
116. 116.
     1. Hsu AA,
     2. Staats BA

     . “Postpolio” sequelae and sleep-related disordered breathing. Mayo Clin Proc 1998;73(3):216–224.

     OpenUrlCrossRefPubMedWeb of Science
117. 117.↵
     1. Labanowski M,
     2. Schmidt-Nowara W,
     3. Guilleminault C

     . Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population. Neurology 1996;47(5):1173–1180.

     OpenUrl
118. 118.↵
     1. Katz SL

     . Assessment of sleep-disordered breathing in pediatric neuromuscular diseases. Pediatrics 2009;123(Suppl 4):S222–S225.

     OpenUrlAbstract/FREE Full Text
119. 119.↵
     1. Pinard JM,
     2. Azabou E,
     3. Essid N,
     4. Quijano-Roy S,
     5. Haddad S,
     6. Cheliout-Héraut F

     . Sleep-disordered breathing in children with congenital muscular dystrophies. Eur J Paediatr Neurol 2012;16(6):619–624.

     OpenUrlCrossRefPubMed
120. 120.↵
     1. Khan Y,
     2. Heckmatt JZ

     . Obstructive apnoeas in Duchenne muscular dystrophy. Thorax 1994;49(2):157–161.

     OpenUrlAbstract/FREE Full Text
121. 121.↵
     1. Mellies U,
     2. Ragette R,
     3. Schwake C,
     4. Boehm H,
     5. Voit T,
     6. Teschler H

     . Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders. Neuromuscul Disord 2003;13(2):123–128.

     OpenUrlCrossRefPubMedWeb of Science
122. 122.↵
     1. Suresh S,
     2. Wales P,
     3. Dakin C,
     4. Harris MA,
     5. Cooper DG

     . Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population. J Paediatr Child Health 2005;41(9):500–503.

     OpenUrlCrossRefPubMedWeb of Science
123. 123.↵
     1. Smith PE,
     2. Calverley PM,
     3. Edwards RH

     . Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis 1988;137(4):884–888.

     OpenUrlPubMedWeb of Science
124. 124.↵
     1. O'Brien LM

     . The neurocognitive effects of sleep disruption in children and adolescents. Child Adolesc Psychiatr Clin N Am 2009;18(4):813–823.

     OpenUrlCrossRefPubMed
125. 125.↵
     1. Ragette R,
     2. Mellies U,
     3. Schwake C,
     4. Voit T,
     5. Teschler H

     . Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 2002;57(8):724–728.

     OpenUrlAbstract/FREE Full Text
126. 126.↵
     1. Simonds AK,
     2. Muntoni F,
     3. Heather S,
     4. Fielding S

     . Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 1998;53(11):949–952.

     OpenUrlAbstract/FREE Full Text
127. 127.↵
     1. Panitch HB

     . Diurnal hypercapnia in patients with neuromuscular disease. Paediatr Respir Rev 2010;11(1):3–8.

     OpenUrlCrossRefPubMed
128. 128.↵
     1. Vianello A,
     2. Bevilacqua M,
     3. Salvador V,
     4. Cardaioli C,
     5. Vincenti E

     . Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest 1994;105(2):445–448.

     OpenUrlCrossRefPubMedWeb of Science
129. 129.↵
     1. Petersen MC,
     2. Wolraich M,
     3. Sherbondy A,
     4. Wagener J

     . Abnormalities in control of ventilation in newborn infants with myelomeningocele. J Pediatr 1995;126(6):1011–1015.

     OpenUrlPubMed
130. 130.↵
     1. Ho G,
     2. Cardamone M,
     3. Farrar M

     . Congenital and childhood myotonic dystrophy: current aspects of disease and future directions. World J Clin Pediatr 2015;4(4):66–80.

     OpenUrl
131. 131.↵
     1. Guilleminault C,
     2. Philip P,
     3. Robinson A

     . Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry 1998;65(2):225–232.

     OpenUrlAbstract/FREE Full Text
132. 132.↵
     1. Hill R,
     2. Robbins AW,
     3. Messing R,
     4. Arora NS

     . Sleep apnea syndrome after poliomyelitis. Am Rev Respir Dis 1983;127(1):129–131.

     OpenUrlPubMedWeb of Science
133. 133.↵
     1. Ward S,
     2. Chatwin M,
     3. Heather S,
     4. Simonds AK

     . Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005;60(12):1019–1024.

     OpenUrlAbstract/FREE Full Text
134. 134.
     1. White JE,
     2. Drinnan MJ,
     3. Smithson AJ,
     4. Griffiths CJ,
     5. Gibson GJ

     . Respiratory muscle activity and oxygenation during sleep in patients with muscle weakness. Eur Respir J 1995;8(5):807–814.

     OpenUrlAbstract
135. 135.↵
     1. Katz SL,
     2. Gaboury I,
     3. Keilty K,
     4. Banwell B,
     5. Vajsar J,
     6. Anderson P,
     7. et al

     . Nocturnal hypoventilation: predictors and outcomes in childhood progressive neuromuscular disease. Arch Dis Child 2010;95(12):998–1003.

     OpenUrlAbstract/FREE Full Text
136. 136.↵
     1. Fromageot C,
     2. Lofaso F,
     3. Annane D,
     4. Falaize L,
     5. Lejaille M,
     6. Clair B,
     7. et al

     . Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil 2001;82(1):123–128.

     OpenUrlCrossRefPubMedWeb of Science
137. 137.↵
     1. Finnimore AJ,
     2. Jackson RV,
     3. Morton A,
     4. Lynch E

     . Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function. Thorax 1994;49(1):66–70.

     OpenUrlAbstract/FREE Full Text
138. 138.↵
     1. Hukins CA,
     2. Hillman DR

     . Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2000;161(1):166–170.

     OpenUrlCrossRefPubMedWeb of Science
139. 139.↵
     1. Bushby K,
     2. Finkel R,
     3. Birnkrant DJ,
     4. Case LE,
     5. Clemens PR,
     6. Cripe L,
     7. et al

     . Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010;9(2):177–189.

     OpenUrlCrossRefPubMedWeb of Science
140. 140.↵
     1. Wang CH,
     2. Dowling JJ,
     3. North K,
     4. Schroth MK,
     5. Sejersen T,
     6. Shapiro F,
     7. et al

     . Consensus statement on standard of care for congenital myopathies. J Child Neurol 2012;27(3):363–382.

     OpenUrlCrossRefPubMedWeb of Science
141. 141.↵
     1. Wang CH,
     2. Bonnemann CG,
     3. Rutkowski A,
     4. Sejersen T,
     5. Bellini J,
     6. Battista V,
     7. et al

     . Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol 2010;25(12):1559–1581.

     OpenUrlCrossRefPubMedWeb of Science
142. 142.↵
     1. Katz SL,
     2. McKim D,
     3. Hoey L,
     4. Barrowman N,
     5. Kherani T,
     6. Kovesi T,
     7. et al

     . Respiratory management strategies for Duchenne muscular dystrophy: practice variation amongst Canadian sub-specialists. Pediatr Pulmonol 2013;48(1):59–66.

     OpenUrlCrossRefPubMed
143. 143.↵
     1. Paiva R,
     2. Krivec U,
     3. Aubertin G,
     4. Cohen E,
     5. Clément A,
     6. Fauroux B

     . Carbon dioxide monitoring during long-term noninvasive respiratory support in children. Intensive Care Med 2009;35(6):1068–1074.

     OpenUrlCrossRefPubMedWeb of Science
144. 144.↵
     1. Bauman KA,
     2. Kurili A,
     3. Schmidt SL,
     4. Rodriguez GM,
     5. Chiodo AE,
     6. Sitrin RG

     . Home-based overnight transcutaneous capnography/pulse oximetry for diagnosing nocturnal hypoventilation associated with neuromuscular disorders. Arch Phys Med Rehabil 2013;94(1):46–52.

     OpenUrl
145. 145.↵
     1. Kirk VG,
     2. Flemons WW,
     3. Adams C,
     4. Rimmer KP,
     5. Montgomery MD

     . Sleep-disordered breathing in Duchenne muscular dystrophy: a preliminary study of the role of portable monitoring. Pediatr Pulmonol 2000;29(2):135–140.

     OpenUrlCrossRefPubMedWeb of Science
146. 146.↵
     1. Passamano L,
     2. Taglia A,
     3. Palladino A,
     4. Viggiano E,
     5. D'Ambrosio P,
     6. Scutifero M,
     7. et al

     . Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients. Acta Myol 2012;31(2):121–125.

     OpenUrlPubMed
147. 147.↵
     1. Mellies U,
     2. Ragette R,
     3. Dohna Schwake C,
     4. Boehm H,
     5. Voit T,
     6. Teschler H

     . Long-term noninvasive ventilation in children and adolescents with neuromuscular disorders. Eur Respir J 2003;22(4):631–636.

     OpenUrlAbstract/FREE Full Text
148. 148.↵
     1. Katz S,
     2. Selvadurai H,
     3. Keilty K,
     4. Mitchell M,
     5. MacLusky I

     . Outcome of non-invasive positive pressure ventilation in paediatric neuromuscular disease. Arch Dis Child 2004;89(2):121–124.

     OpenUrlAbstract/FREE Full Text
149. 149.↵
     1. Young HK,
     2. Lowe A,
     3. Fitzgerald DA,
     4. Seton C,
     5. Waters KA,
     6. Kenny E,
     7. et al

     . Outcome of noninvasive ventilation in children with neuromuscular disease. Neurology 2007;68(3):198–201.

     OpenUrlCrossRef
150. 150.↵
     1. Bach JR,
     2. Bianchi C

     . Prevention of pectus excavatum for children with spinal muscular atrophy type 1. Am J Phys Med Rehabil 2003;82(10):815–819.

     OpenUrlCrossRefPubMedWeb of Science
151. 151.↵
     1. Chatwin M,
     2. Bush A,
     3. Simonds AK

     . Outcome of goal-directed non-invasive ventilation and mechanical insufflation/exsufflation in spinal muscular atrophy type I. Arch Dis Child 2011;96(5):426–432.

     OpenUrlAbstract/FREE Full Text
152. 152.↵
     1. Kennedy JD,
     2. Martin AJ

     . Chronic respiratory failure and neuromuscular disease. Pediatr Clin North Am 2009;56(1):261–273, xii.

     OpenUrlPubMed
153. 153.↵
     1. Laub M,
     2. Berg S,
     3. Midgren B

     . Symptoms, clinical and physiological findings motivating home mechanical ventilation in patients with neuromuscular diseases. J Rehabil Med 2006;38(4):250–254.

     OpenUrlCrossRefPubMed
154. 154.↵
     1. Raphael JC,
     2. Chevret S,
     3. Chastang C,
     4. Bouvet F

     . Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy: French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy. Lancet 1994;343(8913):1600–1604.

     OpenUrlCrossRefPubMedWeb of Science
155. 155.↵
     1. Bach JR,
     2. Niranjan V,
     3. Weaver B

     . Spinal muscular atrophy type I: a noninvasive respiratory management approach. Chest 2000;117(4):1100–1105.

     OpenUrlCrossRefPubMedWeb of Science
156. 156.↵
     1. Sritippayawan S,
     2. Kun SS,
     3. Keens TG,
     4. Davidson Ward SL

     . Initiation of home mechanical ventilation in children with neuromuscular diseases. J Pediatr 2003;142(5):481–485.

     OpenUrlCrossRefPubMedWeb of Science
157. 157.↵
     1. Benditt JO

     . Full-time noninvasive ventilation: possible and desirable. Respir Care 2006;51(9):1005–1012; discussion 1012-1005.

     OpenUrlAbstract/FREE Full Text
158. 158.↵
     1. Boitano LJ,
     2. Benditt JO

     . An evaluation of home volume ventilators that support open-circuit mouthpiece ventilation. Respir Care 2005;50(11):1457–1461.

     OpenUrlAbstract/FREE Full Text
159. 159.↵
     1. Khirani S,
     2. Ramirez A,
     3. Delord V,
     4. Leroux K,
     5. Lofaso F,
     6. Hautot S,
     7. et al

     . Evaluation of ventilators for mouthpiece ventilation in neuromuscular disease. Respir Care 2014;59(9):1329–1337.

     OpenUrlAbstract/FREE Full Text
160. 160.↵
     1. Soudon P,
     2. Steens M,
     3. Toussaint M

     . A comparison of invasive versus noninvasive full-time mechanical ventilation in Duchenne muscular dystrophy. Chron Respir Dis 2008;5(2):87–93.

     OpenUrlCrossRefPubMed
161. 161.↵
     1. Toussaint M,
     2. Steens M,
     3. Wasteels G,
     4. Soudon P

     . Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J 2006;28(3):549–555.

     OpenUrlAbstract/FREE Full Text
162. 162.↵
     1. Britton D,
     2. Benditt JO,
     3. Hoit JD

     . Beyond tracheostomy: noninvasive ventilation and potential positive implications for speaking and swallowing. Semin Speech Lang 2016;37(3):173–184.

     OpenUrl
163. 163.↵
     1. Chatwin M,
     2. Nickol AH,
     3. Morrell MJ,
     4. Polkey MI,
     5. Simonds AK

     . Randomised trial of inpatient versus outpatient initiation of home mechanical ventilation in patients with nocturnal hypoventilation. Respir Med 2008;102(11):1528–1535.

     OpenUrlCrossRefPubMedWeb of Science
164. 164.↵
     1. Bach JR,
     2. Tran J,
     3. Durante S

     . Cost and physician effort analysis of invasive vs. noninvasive respiratory management of Duchenne muscular dystrophy. Am J Phys Med Rehabil 2015;94(6):474–482.

     OpenUrl
165. 165.↵
     1. Carron M,
     2. Freo U,
     3. BaHammam AS,
     4. Dellweg D,
     5. Guarracino F,
     6. Cosentini R,
     7. et al

     . Complications of non-invasive ventilation techniques: a comprehensive qualitative review of randomized trials. Br J Anaesth 2013;110(6):896–914.

     OpenUrlAbstract/FREE Full Text
166. 166.↵
     1. Kelly CR,
     2. Higgins AR,
     3. Chandra S

     . Videos in clinical medicine: noninvasive positive-pressure ventilation. N Engl J Med 2015;372(23):e30.

     OpenUrl
167. 167.↵
     1. Fauroux B,
     2. Lavis JF,
     3. Nicot F,
     4. Picard A,
     5. Boelle PY,
     6. Clément A,
     7. Vazquez MP

     . Facial side effects during noninvasive positive pressure ventilation in children. Intensive Care Med 2005;31(7):965–969.

     OpenUrlCrossRefPubMedWeb of Science
168. 168.
     1. Li KK,
     2. Riley RW,
     3. Guilleminault C

     . An unreported risk in the use of home nasal continuous positive airway pressure and home nasal ventilation in children: mid-face hypoplasia. Chest 2000;117(3):916–918.

     OpenUrlCrossRefPubMedWeb of Science
169. 169.↵
     1. Villa MP,
     2. Pagani J,
     3. Ambrosio R,
     4. Ronchetti R,
     5. Bernkopf E

     . Mid-face hypoplasia after long-term nasal ventilation. Am J Respir Crit Care Med 2002;166(8):1142–1143.

     OpenUrlPubMedWeb of Science
170. 170.↵
     1. Ramirez A,
     2. Delord V,
     3. Khirani S,
     4. Leroux K,
     5. Cassier S,
     6. Kadlub N,
     7. et al

     . Interfaces for long-term noninvasive positive pressure ventilation in children. Intensive Care Med 2012;38(4):655–662.

     OpenUrlCrossRefPubMedWeb of Science
171. 171.↵
     1. Simonds AK

     . Respiratory support for the severely handicapped child with neuromuscular disease: ethics and practicality. Semin Respir Crit Care Med 2007;28(3):342–354.

     OpenUrlPubMed